Retatrutide Coming Soon Retatrutide is an investigational weight loss medication showing promising results in reducing body weight in adults with obesity or overweight
Patients receiving semaglutide (0.5 or 1.0 mg) for 104 weeks demonstrated a significantly higher risk of diabetic retinopathy complications, including vitreous hemorrhage, blindness, or required procedural treatment compared to those receiving placebo (HR, 1.76
Protein quality matters alongside quantity
Melancholic depression exhibits the typical symptoms, while atypical depression shows contrasting features like increased appetite, weight gain, excessive sleep, and improved mood in response to positive events
I did not know there were two
The experience of the treating surgeon is critical here," Dr